Search for: "Ambry Genetics" Results 21 - 40 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Nov 2009, 9:55 pm
Ambry Genetics Corp. 4:09-cv-40200; filed November 18,... [read post]
9 Sep 2013, 4:00 am by Courtenay Brinckerhoff
The hearing on Myriad’s motion for a preliminary injunction against Ambry Genetics is scheduled for September 11, 2013, before Judge Robert A. [read post]
16 Apr 2014, 10:00 pm by Courtenay Brinckerhoff
Myriad has appealed the district court decision that denied its motion for a preliminary injunction against Ambry Genetics Corp. [read post]
13 Oct 2013, 9:54 pm by Patent Docs
This company is thus very different from the more traditional genomics companies like Ambry Genetics, Gene-by-Gene, and Counsyl that... [read post]
19 Mar 2014, 9:59 pm by Patent Docs
By year-end 2013, the litigation scorecard stood at six patent infringement lawsuits pending in the District of Utah, against Ambry Genetics, Gene-by-Gene, Quest, GeneDx, Invitae, and LabCorp, and three declaratory judgment actions by Quest, Invitae, and Counsyl, pending in various California district courts. [read post]
31 Oct 2013, 9:27 pm by Patent Docs
Noonan -- Some of our commenters have asked (with greater or lesser degrees of stridency) that we "take a position" on claims like the Myriad method claims at issue in the lawsuits brought against Ambry Genetics, Gene-by-Gene, and Quest (and purportedly threatened against others). [read post]
6 Oct 2014, 9:00 pm by Dennis Crouch
University of Utah and Myriad Genetics are back at the Federal Circuit after losing a motion for preliminary injunction against the genetic testing company Ambry Genetics. [read post]
10 Feb 2015, 9:59 pm by Patent Docs
With its agreement to dismiss actions (with prejudice) against Ambry Genetics, LabCorp, Invitae, and Pathway Genomics, the earlier settlement agreement reached with Gene-by-Gene... [read post]
7 Aug 2013, 6:23 am by Joe Mullin
Just weeks after it lost at the high court, Myriad filed new lawsuits against the first two competitors who began offering BRCA gene testing, Ambry Genetics and Gene by Gene. [read post]
29 Aug 2013, 4:00 am by John Willinsky
” This would seem to be the case, and all the more so, when the University of Utah Research Foundation launched patent-infringement suits against Ambry Genetics and Gene by Gene on July 9th and 10th, as these two companies had started to provide women with the genetic tests for breast cancer at greatly reduced prices ($2,280 and $995 respectively). [read post]
18 Dec 2014, 11:19 am by Joe Mullin
Instead, it quickly filed a new round of lawsuits, trying to keep competitors like Ambry Genetics out of the business of BRCA testing. [read post]
6 Feb 2013, 7:38 am by Robert Cook-Deegan
  This matters in the practical world of gene testing, because firms like Ambry Genetics have introduced tests for inherited risk of breast and ovarian cancer that cover over a dozen genes. [read post]
19 Aug 2014, 5:10 pm by Dennis Crouch
” The case has been centralized before a multidistrict panel that is handling parallel cases against Gene DX, Quest Diagnostics, Ambry, and Counsyl. [read post]
17 Dec 2014, 9:33 am by Dennis Crouch
 Following the decision, several companies – including Ambry – began marketing BRCA genetic testing, and Myriad sued. [read post]
5 Dec 2014, 10:49 am
His IP practice is focused on the life sciences and medical device industries, and he was selected as a Law360 MVP for his representation of Ambry Genetics. [read post]